Delivery Order SPE2DB20D1109-SPE2DB25FN47E
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Loteprednol Etabonate 0.2% ophthalmic drops, a specialty pharmaceutical product. The contract has a ceiling value of $1,230.16 and is a firm fixed-price contract. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $1,097.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LOTEPREDNOL ETABONATE 0.2% DRP 5ML, a pharmaceutical eye drop product. The contract has an ultimate completion date of December 24, 2024 and is a firm fixed-price contract. AmerisourceBergen, a for-profit organization, is the prime contractor,...
- This federal contract award is for the delivery of Loteprednol Etabonate 0.5% eye drops in 5 mL containers. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on September 16, 2021, with a completion date of September 17, 2021. The ceiling value of the fixed-price delivery order is $5,728.77. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.23 delivery order contract is for the supply of the pharmaceutical product Loteprednol Etabonate 0.5% Ophthalmic Drops, 5 ML. The contract is not designated as a set-aside and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,640.84 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% Eye Drops, 5 ml, with a completion date of July 25, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,051.55, is for the supply of loteprednol etabonate 0.5% eye drops (5 ml) to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Firm Fixed Price agreement and does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,672.09, is for the delivery of Loteprednol Etabonate 0.5% eye drops. The contract is a firm fixed-price delivery order with a completion date of December 19, 2022. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,215.70, is for the delivery of LOTEPREDNOL ETABONATE 0.5% DRP 5ML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and is a Firm Fixed Price Delivery Order. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 milliliter units, with a ceiling value of $1,650.30 and an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government and will be performed at the company's...
- This federal contract award, valued at $3,219.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Loteprednol Etabonate 0.5% Eye Drops, a pharmaceutical product. The contract is a firm fixed-price Delivery Order, with a completion date of December 13, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FN47EDelivery Order
This federal contract award, with the ID SPE2DB20D1109|SPE2DB25FN47E, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Loteprednol Etabonate 0.2% eye drops, a pharmaceutical product, with a ceiling value of $1,107.62 and a completion date of February 3, 2025. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/31/25 |